Actualités Medmira Inc (PK) - MMIRF | Actions OTCMarkets

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

MedMira Wins $4.2 million U.S. Army Contract to Commercialize Rapid Triple Test

MedMira Wins $4.2 million U.S. Army Contract to Commercialize Rapid Triple Test PR Newswire HALIFAX, July 3, 2012 HALIFAX, July 3, 2012...

MedMira Strengthens North American Sales Channels, Adding VWR as Distributor for the United States

HALIFAX, May 28 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid...

MedMira Receives FDA Approval for Reveal G3 Rapid HIV Test - Fastest Rapid HIV Test in the US, Delivering Results in Less Than 3

HALIFAX, Oct. 19 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) a global market leader in premium rapid...

MedMira Announces Leadership Transition - Hermes Chan to Succeed Stephen Sham as CEO

HALIFAX, NS, July 24 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) a global market leader in premium...

MedMira Increases Global Sales Force to Capitalize on Product Approvals

Opportunities in Europe, China, and Developing Nations Being Pursued HALIFAX, June 29 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX...

MedMira Completes Acquisition of BAG-1 Technology

HALIFAX, May 25 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in premium rapid...

China SFDA Approves MedMira's Whole Blood Rapid HIV Test

Approval Opens Point-of-Care and Home Testing Markets in China HALIFAX, May 17 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture:...

MedMira Grows Rapid HIV Test Sales in Latin America

Receives Product Registration and Initial Order for Argentina HALIFAX, April 20 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX...

MedMira Acquires Technology to Develop New Tests for Cancer

Emerging Cancer Markers Commercialized Through Maple Biosciences HALIFAX, April 3 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX...

MedMira Files Patent for Over-the-Counter Testing System

Home HIV Test First in MedMira's New Self-Care Product Line HALIFAX, March 23 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture:...

MedMira Resumes Sales to the Middle East

Instant HIV Tests Destined for UAE as Demand Increases for Immigration and Emergency Care HALIFAX, March 21 /PRNewswire-FirstCall/ -- MedMira...

MedMira Closes $6.5M in Funding from Morningside

New Institutional Equity Funding Brings Strategic Partner and Fuels Growth Plans for MedMira HALIFAX, March 17 /PRNewswire-FirstCall/ -- MedMira...

MedMira to Present at FDA Meeting on Home-Use HIV Tests

HALIFAX, March 8 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in premium rapid...

MedMira Invites Investment Analysts to Conference Call

HALIFAX, March 7 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in premium rapid...

MedMira Secures $6.5M in Institutional Equity Financing

Morningside becomes a Strategic Partner to Accelerate MedMira's Growth HALIFAX, March 6 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Medmira Inc (PK) (MMIRF)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

MMIRF Actualités

MedMira Wins $4.2 million U.S. Army Contract to Commercialize Rapid Triple Test

MedMira Strengthens North American Sales Channels, Adding VWR as Distributor for the United States

MedMira Receives FDA Approval for Reveal G3 Rapid HIV Test - Fastest Rapid HIV Test in the US, Delivering Results in Less Than 3

MedMira Announces Leadership Transition - Hermes Chan to Succeed Stephen Sham as CEO

MedMira Increases Global Sales Force to Capitalize on Product Approvals

MedMira Completes Acquisition of BAG-1 Technology

China SFDA Approves MedMira's Whole Blood Rapid HIV Test

MedMira Grows Rapid HIV Test Sales in Latin America

MedMira Acquires Technology to Develop New Tests for Cancer

MedMira Files Patent for Over-the-Counter Testing System

MedMira Resumes Sales to the Middle East

MedMira Closes $6.5M in Funding from Morningside

MedMira to Present at FDA Meeting on Home-Use HIV Tests

MedMira Invites Investment Analysts to Conference Call

MedMira Secures $6.5M in Institutional Equity Financing

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Medmira Inc (PK) (MMIRF) Actualités

Medmira Inc (PK) (MMIRF)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

MMIRF Actualités

MedMira Wins $4.2 million U.S. Army Contract to Commercialize Rapid Triple Test

MedMira Strengthens North American Sales Channels, Adding VWR as Distributor for the United States

MedMira Receives FDA Approval for Reveal G3 Rapid HIV Test - Fastest Rapid HIV Test in the US, Delivering Results in Less Than 3

MedMira Announces Leadership Transition - Hermes Chan to Succeed Stephen Sham as CEO

MedMira Increases Global Sales Force to Capitalize on Product Approvals

MedMira Completes Acquisition of BAG-1 Technology

China SFDA Approves MedMira's Whole Blood Rapid HIV Test

MedMira Grows Rapid HIV Test Sales in Latin America

MedMira Acquires Technology to Develop New Tests for Cancer

MedMira Files Patent for Over-the-Counter Testing System

MedMira Resumes Sales to the Middle East

MedMira Closes $6.5M in Funding from Morningside

MedMira to Present at FDA Meeting on Home-Use HIV Tests

MedMira Invites Investment Analysts to Conference Call

MedMira Secures $6.5M in Institutional Equity Financing

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités